2-((3-Cyano-4-phenyl-6-(p-tolyl)pyridin-2-yl)thio)-N-(2-methyl-5-nitrophenyl)acetamide

Catalog No. :
ACOIBR298
CAS No. :
444152-07-2
Molecular Formula :
C28H22N4O3S
Molecular Weight :
494.58

IUPAC Name:2-((3-cyano-4-phenyl-6-(p-tolyl)pyridin-2-yl)thio)-N-(2-methyl-5-nitrophenyl)acetamide

2-((3-Cyano-4-phenyl-6-(p-tolyl)pyridin-2-yl)thio)-N-(2-methyl-5-nitrophenyl)acetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$271.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-((3-Cyano-4-phenyl-6-(p-tolyl)pyridin-2-yl)thio)-N-(2-methyl-5-nitrophenyl)acetamide
IUPAC Name2-((3-cyano-4-phenyl-6-(p-tolyl)pyridin-2-yl)thio)-N-(2-methyl-5-nitrophenyl)acetamide
MDL No.MFCD01326225
Molecular FormulaC28H22N4O3S
Molecular Weight494.58
SMILESO=C(NC1=CC([N+]([O-])=O)=CC=C1C)CSC2=NC(C3=CC=C(C)C=C3)=CC(C4=CC=CC=C4)=C2C#N
InChI KeyWQYFXKBBJJYPDH-UHFFFAOYSA-N
Synonym2-[3-cyano-6-(4-methylphenyl)-4-phenylpyridin-2-yl]sulfanyl-N-(2-methyl-5-nitrophenyl)acetamide
CAS No.444152-07-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACOIBR298 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACOIBR298 route product structure diagram
    ACOIBR298444152-07-2
Inquiry

2. ACOIBR298 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACOIBR298 route product structure diagram
    ACOIBR298444152-07-2
Inquiry

Comments (0)